TPP1 and neuronal ceroid lipofuscinosis: TPP1-containing EVs were also administered intraperitoneally and led to the accumulation of TPP1-EVs in brain tissue, improving the lifespan of the late-infantile neuronal ceroid lipofuscinosis mouse (Haney et al., 2019).